320 related articles for article (PubMed ID: 29185901)
1. Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial.
Gee MS; Atri M; Bandos AI; Mannel RS; Gold MA; Lee SI
Radiology; 2018 Apr; 287(1):176-184. PubMed ID: 29185901
[TBL] [Abstract][Full Text] [Related]
2. Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial.
Atri M; Zhang Z; Dehdashti F; Lee SI; Marques H; Ali S; Koh WJ; Mannel RS; DiSilvestro P; King SA; Pearl M; Zhou X; Plante M; Moxley KM; Gold M
Radiology; 2017 May; 283(2):450-459. PubMed ID: 28051912
[TBL] [Abstract][Full Text] [Related]
3. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
Konuralp Atakul B; Taşkın S; Soydal Ç; Sükür YE; Kahraman A; Koyuncu K; İbiş E; Ortac F
Gynecol Obstet Invest; 2017; 82(4):340-348. PubMed ID: 27771729
[TBL] [Abstract][Full Text] [Related]
4. Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases.
Stecco A; Buemi F; Cassarà A; Matheoud R; Sacchetti GM; Arnulfo A; Brambilla M; Carriero A
Radiol Med; 2016 Jul; 121(7):537-45. PubMed ID: 27033474
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it.
Nogami Y; Banno K; Irie H; Iida M; Kisu I; Masugi Y; Tanaka K; Tominaga E; Okuda S; Murakami K; Aoki D
Jpn J Clin Oncol; 2015 Jan; 45(1):26-34. PubMed ID: 25368102
[TBL] [Abstract][Full Text] [Related]
6. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients.
Crivellaro C; Landoni C; Elisei F; Buda A; Bonacina M; Grassi T; Monaco L; Giuliani D; Gotuzzo I; Magni S; Di Martino G; Delle Marchette M; Guerra L; Landoni F; Fruscio R; Messa C; De Bernardi E
Int J Gynecol Cancer; 2020 Mar; 30(3):378-382. PubMed ID: 32079712
[TBL] [Abstract][Full Text] [Related]
7.
Mayoral M; Paredes P; Domènech B; Fusté P; Vidal-Sicart S; Tapias A; Torné A; Pahisa J; Ordi J; Pons F; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2017; 36(1):20-26. PubMed ID: 27667001
[TBL] [Abstract][Full Text] [Related]
8. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
10. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
Signorelli M; Guerra L; Buda A; Picchio M; Mangili G; Dell'Anna T; Sironi S; Messa C
Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study.
Tanaka T; Terai Y; Yamamoto K; Yamada T; Ohmichi M
Medicine (Baltimore); 2018 Sep; 97(38):e12522. PubMed ID: 30235772
[TBL] [Abstract][Full Text] [Related]
12. The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
Park JY; Lee JJ; Choi HJ; Song IH; Sung CO; Kim HO; Chae SY; Kim YT; Nam JH
Ann Surg Oncol; 2017 Aug; 24(8):2303-2310. PubMed ID: 28550488
[TBL] [Abstract][Full Text] [Related]
13. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
Fasmer KE; Gulati A; Dybvik JA; Ytre-Hauge S; Salvesen Ø; Trovik J; Krakstad C; Haldorsen IS
Eur Radiol; 2020 May; 30(5):2443-2453. PubMed ID: 32034487
[TBL] [Abstract][Full Text] [Related]
14. What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
Botsikas D; Bagetakos I; Picarra M; Da Cunha Afonso Barisits AC; Boudabbous S; Montet X; Lam GT; Mainta I; Kalovidouri A; Becker M
Eur Radiol; 2019 Apr; 29(4):1787-1798. PubMed ID: 30267154
[TBL] [Abstract][Full Text] [Related]
15. Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial.
Atri M; Zhang Z; Dehdashti F; Lee SI; Ali S; Marques H; Koh WJ; Moore K; Landrum L; Kim JW; DiSilvestro P; Eisenhauer E; Schnell F; Gold M
Gynecol Oncol; 2016 Sep; 142(3):413-9. PubMed ID: 27178725
[TBL] [Abstract][Full Text] [Related]
16. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
17. [
Adam JA; van Diepen PR; Mom CH; Stoker J; van Eck-Smit BLF; Bipat S
Gynecol Oncol; 2020 Nov; 159(2):588-596. PubMed ID: 32921477
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer.
Park JY; Kim EN; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2008 Mar; 108(3):486-92. PubMed ID: 18201753
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
[TBL] [Abstract][Full Text] [Related]
20. Cervical ultrasonography has no additional value over negative
Goense L; Meziani J; van Rossum PSN; Wessels FJ; Lam MGEH; van Hillegersberg R; Ruurda JP
Eur Radiol; 2018 May; 28(5):2031-2037. PubMed ID: 29218619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
